Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Norgine to commercialize Shield’s iron deficiency therapy in Europe, Australia and New Zealand
Image: Shield Therapeutics and Norgine to commercialise Feraccru in Europe, Australia and New Zealand. Photo: courtesy of adamr / FreeDigitalPhotos.net.
Image: Shield Therapeutics and Norgine to commercialise Feraccru in Europe, Australia and New Zealand. Photo: courtesy of adamr / FreeDigitalPhotos.net.